Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul;35(7):673-683.
doi: 10.1007/s40273-017-0508-2.

Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview

Affiliations
Review

Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview

Erik J Dasbach et al. Pharmacoeconomics. 2017 Jul.

Abstract

Decision-analytic models for cost-effectiveness analysis are developed in a variety of software packages where the accuracy of the computer code is seldom verified. Although modeling guidelines recommend using state-of-the-art quality assurance and control methods for software engineering to verify models, the fields of pharmacoeconomics and health technology assessment (HTA) have yet to establish and adopt guidance on how to verify health and economic models. The objective of this paper is to introduce to our field the variety of methods the software engineering field uses to verify that software performs as expected. We identify how many of these methods can be incorporated in the development process of decision-analytic models in order to reduce errors and increase transparency. Given the breadth of methods used in software engineering, we recommend a more in-depth initiative to be undertaken (e.g., by an ISPOR-SMDM Task Force) to define the best practices for model verification in our field and to accelerate adoption. Establishing a general guidance for verifying models will benefit the pharmacoeconomics and HTA communities by increasing accuracy of computer programming, transparency, accessibility, sharing, understandability, and trust of models.

PubMed Disclaimer

References

    1. Med Decis Making. 2017 May;37(4):340-352 - PubMed
    1. Cell. 2012 Jul 20;150(2):389-401 - PubMed
    1. Pharmacoeconomics. 2016 Apr;34(4):349-61 - PubMed
    1. BMJ. 2015 Nov 11;351:h5441 - PubMed
    1. Med Decis Making. 2016 Nov;36(8):952-64 - PubMed

LinkOut - more resources